<!DOCTYPE html>
<html>
<head>
<title>CV Sciences, Inc. Annual report pursuant to Section 13 and 15(d)</title>
<link href="https://ir.cvsciences.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://ir.cvsciences.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Annual report pursuant to Section 13 and 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1513">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1513">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1514">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1514">CONSOLIDATED BALANCE SHEETS</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1515">CONSOLIDATED BALANCE SHEETS (Parenthetical)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1516">CONSOLIDATED STATEMENTS OF OPERATIONS</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1517">CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1518">CONSOLIDATED STATEMENTS OF CASH FLOW</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1519">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1519">ORGANIZATION AND BUSINESS</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1520">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1521">INVENTORY</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1522">PROPERTY & EQUIPMENT</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1523">INTANGIBLE ASSETS</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1524">ACCRUED EXPENSES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1525">NOTES PAYABLE</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1526">RELATED PARTIES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1527">STOCKHOLDERS EQUITY</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1528">STOCK-BASED COMPENSATION</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1529">NET INCOME (LOSS) PER SHARE</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1530">COMMITMENTS AND CONTINGENCIES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1531">LEASES LEASES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1532">SEGMENT INFORMATION</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1533">INCOME TAXES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1534">SUBSEQUENT EVENT</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1535">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1535">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1536">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1536">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1537">INVENTORY (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1538">PROPERTY & EQUIPMENT (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1539">INTANGIBLE ASSETS (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1540">ACCRUED EXPENSES (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1541">STOCK-BASED COMPENSATION (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1542">NET INCOME (LOSS) PER SHARE (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1543">LEASES (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1544">SEGMENT INFORMATION (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1545">INCOME TAXES (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1546">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1546">Organization and Business (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1547">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Cash)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1548">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1549">INVENTORY (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1550">PROPERTY & EQUIPMENT (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1551">INTANGIBLE ASSETS (Details - Intangible asset schedule)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1552">INTANGIBLE ASSETS (Details - Future amortization expense)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1553">ACCRUED EXPENSES (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1554">NOTES PAYABLE (Details - Unsecured Note Payable)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1555">RELATED PARTIES (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1556">STOCKHOLDERS EQUITY (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1557">STOCK-BASED COMPENSATION (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1558">STOCK-BASED COMPENSATION (Details - Option activity)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1559">STOCK-BASED COMPENSATION (Details - Assumptions)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1560">STOCK-BASED COMPENSATION (Details - Unvested)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1561">NET INCOME (LOSS) PER SHARE (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1562">NET INCOME (LOSS) PER SHARE Antidilutive Shares (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1563">COMMITMENTS AND CONTINGENCIES - Lawsuits (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1564">LEASES (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1565">LEASES Right-of-use Assets and Lease Liabilities (Details) (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1566">LEASES Maturity of Lease Liabilities (Details) (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1567">LEASES Operating Lease Commitments under ASC 840 (Details) (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1568">SEGMENT INFORMATION (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1569">INCOME TAXES INCOME TAXES (Components of income tax expense) (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1570">INCOME TAXES (Details-Income tax provision)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1571">INCOME TAXES (Details-Deferred income taxes)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1572">INCOME TAXES (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/annual-reports/xbrl_doc_only/1573">SUBSEQUENT EVENT (Details)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>NET INCOME (LOSS) PER SHARE (Tables)</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>